Roux-en-Y gastri0063 bypass (RYGB), while efficacious for weight reduction, encompasses a spectrum of potential long-term adverse outcomes, encompassing both surgical and nonsurgical complications such as malnutrition, marginal ulceration, internal hernia, chronic diarrhea, and postprandial hypoglycemia. Among these, chronic diarrhea—characterized by the presence of three or more loose stools daily for a duration exceeding 4 weeks, coupled with a fecal weight surpassing 200 g per day—emerges as a significant postoperative concern.
